Hailong Li
- Molecular Biology
- Oncology top 10%
- Immunology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 10%
- Topics
- CAR-T cell therapy research (6 papers)Bladder and Urothelial Cancer Treatments (6 papers)Urinary and Genital Oncology Studies (5 papers)
- Journals
- Cancer ResearchGutScientific Reports
- Partner nations
- ChinaUnited StatesVietnam
In The Last Decade
Hailong Li
56 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Molecular Biology 627
- Oncology 306
- Immunology 210
- Pulmonary and Respiratory Medicine 209
- Cancer Research 179
Countries citing papers authored by Hailong Li
This map shows the geographic impact of Hailong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailong Li more than expected).
Fields of papers citing papers by Hailong Li
This network shows the impact of papers produced by Hailong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailong Li. The network helps show where Hailong Li may publish in the future.
Co-authorship network of co-authors of Hailong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Hailong Li. A scholar is included among the top collaborators of Hailong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailong Li. Hailong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 9 | |
| 8 | 5 | |
| 9 | 5 | |
| 10 | 3 | |
| 11 | 3 | |
| 12 | 6 | |
| 13 | 30 | |
| 14 | Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turnbreakdown → | 203 |
| 15 | 19 | |
| 16 | 35 | |
| 17 | 11 | |
| 18 | 28 | |
| 19 | 32 | |
| 20 | 58 |
About Hailong Li
Hailong Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Bladder and Urothelial Cancer Treatments (6 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Biological Psychiatry (32 citations), Cancer Research (179 citations) and Neurology (98 citations). Hailong Li has collaborated with scholars based in China, United States and Vietnam. Frequent co-authors include Junnian Zheng, Jin Bai, Huizhong Li, Jiage Ding, Qing Zhang, Hongyan Liu, Mengmeng Lü, Junnian Zheng, Liantao Li and Meilin Shi. Their work appears in journals such as Cancer Research, Gut and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.